TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NUVL

Nuvalent Inc

Healthcare · Biotechnology

124.00$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Income Statement

Nuvalent Inc (NUVL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NUVL
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
26 30 36 39 49 61 69 74 81 84 68 84 316
8.1 9.2 11 14 16 16 17 20 24 29 34 36 123
34 39 46 53 65 76 86 95 105 113 102 119 439
-34 -39 -46 -53 -65 -76 -86 -95 -105 -113 -102 -119 -439
5.0 5.1 18 8.5 8.2 8.6 – 12 – 10 – 13 –
-29 -34 -38 -44 -57 -84 -75 -84 -100 -122 -119 -109 -449
-0.1 0.0 5.0 0.4 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.6
-29 -34 -38 -44 -57 -84 -75 -85 -100 -122 -119 -109 -450
-29 -34 -36 -44 -57 -84 -75 -84 -100 -122 -16 -96 -334

LTM = last twelve months (sum of the four most recent quarters).

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?